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Bicyclic Pyrrolidine-Isoxazoline γ
Amino Acid: A Constrained Scaffold
for Stabilizing α-Turn Conformation
in Isolated Peptides
Francesco Oliva 1, Raffaella Bucci 2, Lucia Tamborini 2, Stefano Pieraccini 1*, Andrea Pinto 3*
and Sara Pellegrino 2*
1Department of Chemistry, University of Milan, Milan, Italy, 2Department of Pharmaceutical Sciences, University of Milan,
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Unnatural amino acids have tremendously expanded the folding possibilities
of peptides and peptide mimics. While α,α-disubstituted and β-amino
acids are widely studied, γ-derivatives have been less exploited. Here we
report the conformational study on the bicyclic unnatural γ amino acid,
4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-3-carboxylic acid 1. In model peptides,
the (+)-(3aR6aS)-enantiomer is able to stabilize α-turn conformation when associated
to glycine, as showed by 1H-NMR, FT-IR, and circular dichroism experiments, and
molecular modeling studies. α-turn is a structural motif occurring in many biologically
active protein sites, although its stabilization on isolated peptides is quite uncommon.
Our results make the unnatural γ-amino acid 1 of particular interest for the development
of bioactive peptidomimetics.
Keywords: unnatural γ-amino acids, peptidomimetic, isoxazoline, α-turn, metadynamic studies, conformational
analysis
INTRODUCTION
Amino acids are the key building blocks of proteins and biomolecules and are widely exploited
in different applications, from pharmaceutical chemistry and biomedicine to material science,
optoelectronics and catalysis (Zhang et al., 2012; Mikhalevich et al., 2017; Solomon et al., 2017;
López-Andarias et al., 2018; Raymond and Nilsson, 2018). The insertion of unnatural amino acids
(UAAs) in peptides and peptide mimics could add specific features to these molecules, such as
proteolytic stability, active functional groups and new reactivity (Clerici et al., 2016; Pellegrino
et al., 2016, 2017; Bucci et al., 2017). α,α disubstituted and β- homologs of natural amino acids have
been particularly studied during the years for their ability to introduce conformational constrains
in peptides and to stabilize specific secondary structures (Bonetti et al., 2015; Pellegrino et al., 2015;
Fanelli et al., 2017; Kobayashi et al., 2017). On the other hand, γUAAs provide a further opportunity
to engineer the available backbone through the incorporation of an additional methylene group
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(Vasudev et al., 2011; Sohora et al., 2018). Recent studies report
that γ-peptides are able to form helices, sheets and turns, whose
conformational stability is increased by introducing substituents
on the backbone chain (Bouillère et al., 2011). Moreover, cyclic
γ UAAs, as gabapentin (Gpn) (Chatterjee et al., 2009; Konda
et al., 2018) and γ-cyclohexyl amino acid (Guo et al., 2012) are
able to stabilize both turn and helix conformation in oligomers
and in mixed α-γ and β-γ sequences. On the other hand, the
use of bicyclic γ amino acids for the stabilization of the peptide
structure is much less investigated (Machetti et al., 2000).
In this work, we investigated the conformational behavior
of both the enantiomers of the bicyclic unnatural γ amino acid
4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-3-carboxylic
acid 1, obtained starting from the corresponding ethyl esters
recently described by us (Tamborini et al., 2015). Compound
1 is a conformationally constrained dipeptide analog and, in
principle, it could substitute two amino acids in a peptide chain.
The presence of the constrained bicyclic system could induce
specific secondary structure allowing a proper orientation of the
peptide arms at C- and N- termini. Furthermore, the presence
of the isoxazoline ring, a core often found in biologically active
compounds, could be particularly useful for future applications
in the pharmaceutical field. In fact, isoxazoline derivatives
are important scaffolds found in many naturally occurring
and biologically active compounds possessing a wide range of
bioactivities, such as antibacterial, antifungal, antiparasitic (Conti
et al., 2011; Bruno et al., 2014; Pinto et al., 2016a), anticancer
(Castellano et al., 2011; Kaur et al., 2014), anti-inflammatory and
anticonvulsant activity (Sperry and Wright, 2005; Pinto et al.,
2011, 2016b). Isoxazolines are also considered to be important
precursors for the synthesis of β-hydroxyketones (Kozikowski
and Park, 1990; Tsantali et al., 2007), β-aminoalcohols (Fuller
et al., 2005), isoxazolidines (Itoh et al., 2002), and many other
valuable compounds. Recently, peptidomimetics containing the
isoxazoline ring have been reported as β-turn mimics (Bucci
et al., 2018; Memeo et al., 2018).
Starting from the (–)-(3aS6aR)-1 and (+)-(3aR6aS)-1
enantiomers, model peptides containing Leu-Val dipeptide
at C-terminus and variable sequences at N-terminus were
prepared. Their conformational behavior was investigated by
NMR spectroscopy, FT-IR, circular dichroism, and molecular
modeling. Our results indicated that (+)-(3aR6aS)-1 enantiomer,
in combination with glycine, is effective in stabilizing the α-turn
conformation in peptides (Figure 1). This structural motif occurs
quite often in many key sites of proteins, such as enzyme active
site, and metal binding domains (Wintjens et al., 1996), although
few molecules are known to mimic or stabilize it on isolated
peptides (Kelso et al., 2004; Hoang et al., 2011; Krishna et al.,
2014; Wang et al., 2018.). Our results make thus the unnatural
γ-amino acid 1 of particular interest for future development of
bioactive peptidomimetics.
Abbreviations: ACN, Acetonitrile; Boc, tert-butyloxycarbonyl; DIEA,
N,N-Diisopropylethylamine; DMF, Dimethylformamide; EDC, 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide; Gly, Glycine; HOBt, Hydroxybenzotriazole;
Leu, Leucine; Phe, Phenylalanine; TFA, Trifluoroacetic acid; Val, Valine.
MATERIALS AND METHODS
Materials
Chemicals were obtained from Zentek (Italy) and used without
further purification. Melting points were determined in a Stuart
Scientific melting point apparatus in open capillary tubes and
are certified. ESI mass spectra were recorded on an LCQESI. MS
was recorded on a LCQ Advantage spectrometer from Thermo
Finningan and a LCQ Fleet spectrometer fromThermo Scientific.
CD experiments were carried out on a Jasco J-810 instrument.
Spectra were obtained from 195 to 250 nm with a 0.1 nm step
and 1 s collection time per step, taking three averages. The CD
spectra were plotted as mean residue ellipticity θ (degree ×
cm2 × dmol−1) vs. wave length λ (nm). Noise-reduction was
obtained using a Fourier-transform filter program from Jasco.
The NMR spectroscopic experiments were carried out on a
Varian OXFORD 300 MHz (300 and 75 MHz for 1H and 13C,
respectively). Chemical shifts, δ, are given in ppm relative to
the CHCl3 internal standard, and the coupling constants, J, are
reported in hertz (Hz).
Methods
Synthesis of (–)-(3aS,6aR)-1 and (+)-(3aR,6aS)-1
Compound (–)-2 or (+)-2 (200mg, 0.70 mmol) was dissolved
in MeOH (3.0mL) and treated with 1N NaOH aqueous solution
(1.4mL). The mixture was stirred at room temperature for 1 h
and the disappearance of the starting material was monitored by
TLC (Cyclohexane/EtOAc 7:3). The mixture was diluted in water
(20mL), made acidic with 2N aqueous HCl and extracted with
EtOAc. The organic phase was dried over anhydrous Na2SO4 and
after evaporation of the solvent, the acid derivate (–)-(3aS,6aR)-1
or (+)-(3aR,6aS)-1 (170mg, 95%) was obtained as a white solid.
(–)-(3aS,6aR)-1: Rf (CH2Cl2/MeOH 9:1 + 1% AcOH): 0.40;
[α]20D : (–) 192.2 (c: 0.55 in MeOH); mp = dec. T > 137
◦C; 1H
NMR (300 MHz, CD3OD): δ 5.35 (dd, J = 4.8, 9.2, 1H); 4.10
(ddd, J = 2.2, 9.2, 9.2, 1H); 3.86–3.96 (m, 2H); 3.38–3.50 (m, 2H);
1.44 (s, 9H) ppm; 13CNMR (75MHz, CD3OD): δ 161.28, 154.77,
152.95, 87.62, 80.33, 53.06, 50.93, 49.10, 27.12 (3C) ppm.
HRMS (ESI) [M + Na]+ calculated for C11H16N2O5Na:
279.0957, found: 279.0950.
(+)-(3aR,6aS)-1: [α]20D : (+) 192.5 (c: 0.57 in MeOH).
General Procedure for Coupling Reaction
Free carboxylic acid (1 equiv.) was dissolved in CH2Cl2 (0.01M
solution) and the mixture was cooled to 0◦C. HOBt (1.1
equiv.) and EDC (1.1 equiv.) were added. After 1 h, free amino
compound (1 equiv.) was added, followed by the addition of
DIEA (2 equiv.). The reaction mixture was stirred at room
temperature for 24 overnight (TLC analysis). The organic layer
was washed with a 5% solution of KHSO4 (3 times), with
a saturated solution of NaHCO3 (3 times) and with brine
(1 time). The organic phase was dried over Na2SO4 and the
solvent was removed under vacuum. The products were purified
by column flash chromatography on silica gel (hexane/ethyl
acetate gradient) followed by a crystallization from a mixture of
ethyl acetate/hexane.
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FIGURE 1 | Natural α-turn and the proposed α-turn mimic containing the bicyclic pyrrolidine-isoxazoline γ amino acid.
Product Yield (%) Product Yield (%)
N-Boc-Leu-Val-CONHa2 96 8 77
4 65 9 80
5 63 10 65
asee Steinke and Kula (1990).
N-Boc-(–)-∆2-isox-Leu-Val-CONH2 (4)
1H NMR (300 MHz, CDCl3): δ 7.11 (bs, 1H), 6.88 (d, J = 8.8Hz,
1H), 6.19 (bs, 1H), 5.72 (bs, 1H), 5.34–5.29 (m, 1H), 4.56–4.48
(m, 1H), 4.31 (dd, J = 8.2; 6.9Hz, 1H), 4.17–3.83 (m, 3H), 3.56 –
3.42 (m, 2H), 2.23–2.07 (m, 1H), 1.85–1.61(m, 3H), 1.43 (s, 9H),
0.99 – 0.92 (m, 12H) ppm.
13C NMR (75 MHz, CDCl3): δ 173.04, 171.32, 159.44, 154.28,
153.93, 87.40, 80.43, 58.24, 53.26, 52.30, 50.53, 49.32, 40.87, 30.53,
28.31, 24.82, 22.91, 21.92, 19.27, 17.93 ppm.
HRMS (ESI) [M + Na]+ calculated for C22H37N5O6Na:
490.2642, found: 490.2635.
N-Boc- (+)-∆2-isox-Leu-Val-CONH2 (5)
1H NMR (300 MHz, CDCl3): δ 7.05 (bs, 1H), 6.73 (d, J = 7.9Hz,
1H), 6.13 (bs, 1H), 5.69 (bs, 1H), 5.37–5.28 (m, 1H), 4.56–4.47 (m,
1H), 4.36–4.27 (m, 1H), 4.18–4.07 (m, 1H), 3.99–3.77 (m, 2H),
3.61–3.41 (m, 2H), 2.28–2.10 (m, 1H), 1.78–1.57(m, 3H), 1.49 (s,
9H), 1.01 – 0.90 (m, 12H) ppm.
13C NMR (75 MHz, CDCl3): δ 173.16, 171.54, 159.33, 154.16,
153.96, 80.34, 60.38, 58.16, 53.27, 52.25, 49.41, 41.02, 30.67, 28.32,
24.83, 22.87, 21.99, 19.20, 18.02 ppm.
HRMS (ESI) [M + Na]+ calculated for C22H37N5O6Na:
490.2642, found: 490.2635.
NH-Boc-Phe-(-)-∆2-isox-Leu-Val-CONH2 (8) –Mixture of
two conformers-
1H NMR (300 MHz, CDCl3): δ 7.36–7.16 (m, 5H), 7.15–7.08 (m,
1H), 7.05–6.97 (m, 1H), 6.88–6.77 (m, 1H), 6.05 (bs, 1H), 5.71
(bs, 1H), 5.43 (d, J = 8.4Hz 1H), 5.33–5.22 (m, 3H), 5.09–4.9 (m,
1H), 4.64–4.44 (m, 3H), 4.33–4.23 (m, 2H), 4.17–4.03 (m, 2H),
3.99–3.91 (m, 1H), 3.87–3.75(m, 2H), 3.70–3.50 (m, 2H), 3.42–
3.30 (m, 1H), 3.13–3.03 (m, 1H), 2.97–2.74 (m, 3H), 2.51(dd, J
= 12.2; 4.8Hz, 1H), 2.21–2.05(m, 1H), 1.51–1.33 (m, 9H), 1.06 –
0.84 (m, 12H) ppm.
13C NMR (75 MHz, CDCl3): δ 172.91, 171.38, 170.09, 159.11,
157.88, 157.30, 153.83, 152.33, 136.34, 129.46, 129.30, 128.56,
128.44, 127.12, 126.85, 96.33, 87.21, 85.98, 58.09, 53.31, 52.77,
52.36, 50.95, 49.64, 49.00, 48.59, 41.05, 40.91, 30.83, 30.62, 29.69,
28.35, 24.84, 22.81, 22.71, 19.18, 17.94 ppm.
HRMS (ESI) [M + Na]+ calculated for C31H46N6O7Na:
637.3326, found: 637.3332.
NH-Boc-Phe-(+)-∆2-isox-Leu-Val-CONH2 (9) –Mixture of
two conformers-
1H NMR (300 MHz, CDCl3): δ 7.33–7.05 (m, 6H) 7.04–6.91 (m,
1H), 6.70 (d, J = 8.5Hz, 1H), 6.13–5.91 (m, 2H), 5.46 (d, J =
8.5Hz, 1H), 5.36–5.10 (m, 2H), 4.87–4.71 (m, 1H), 4.67–4.43 (m,
1H), 4.38–4.23 (m, 2H), 4.23–3.69 (m, 4H), 3.69–3.41 (m, 1H),
3.21 (dd, J=14.3, J=5.0Hz, 1H), 3.10–2.79 (m, 2H), 2.54 (dd,
J=14.3, J=5.0Hz, 1H), 2.30–1.99 (m, 1H), 1.89–1.55 (m, 3H),
1.49 (m, 9H), 1.31 (m, 12H) ppm.
13C NMR (75 MHz, CDCl3): δ 173.14, 172.90, 171.92, 171.23,
170.66, 170.49, 159.68, 158.86, 155.92, 155.18, 153.77. 153.59,
136.00, 129.63, 129.43, 129.15, 128.60, 128.41, 127.14, 127.05,
86.96, 85.53, 79.99, 79.88, 58.23, 57.68, 54.13, 53.47, 52.97, 52.19,
51.05, 48.82, 41.04, 40.85, 39.32, 30.88, 30.66, 28.45, 28.30, 25.05,
24.81, 22.91, 22.01, 21.51, 19.28, 17.98, 17.84 ppm.
HRMS (ESI) [M + Na]+ calculated for C31H46N6O7Na:
637.3326, found: 637.3332.
NH-Boc-Phe-Gly-(+)-∆2-isox-Leu-Val-CONH2 (10)
1H NMR (300 MHz, CD3CN): δ 7.47 (d, J = 6.9Hz, 1H), 7.30–
7.26 (m, 6H), 6.95 (d, J = 8.5Hz, 1H), 6.72 (bs, 1H), 6.42 (bs, 1H),
5.63 (bs, 1H), 5.47–5.31 (m, 1H), 4.52–4.47 (m, 1H), 4.40–3.39
(m, 8H), 3.23–3.07 (m, 1H), 2.70–2.93 (m, 1H), 2.14–2.08 (m,
1H), 1.78–1.55 (m, 3H), 1.35 (s, 9H), 1.02–0.77 (m, 12H) ppm.
13CNMR (75MHz, CD3CN): δ 173.43, 171.63, 167.09, 159.52,
154.34, 137.64, 129.27, 128.31, 126.53, 109.99, 87.41, 86.02, 79.09,
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58.06, 56.82, 55.76, 53.67, 52.65, 51.39, 49.79, 48.71, 41.62, 40.43,
40.10, 37.60, 31.51, 30.55, 29.34, 27.49, 24.77, 22.27, 20.81, 18.86,
17.21, 16.63 ppm.
HRMS (ESI) [M + Na]+ calculated for C33H49N7O8Na:
694.3540, found: 694.3539.
General Procedure for N-Boc-Deprotection
N-Boc protected compound (1 equiv.) was dissolved in CH2Cl2
(0.01M) and the solution cooled at 0◦C. TFA (50% v/v) was added
dropwise, the solution was warmed up at room temperature and
was stirred for 2 h. The solvent was removed under vacuum with
the obtainment of the trifluoroacetate salt that was directly used
in the next coupling step.
Product Yield (%)
3a 95
6 95
7 95
a see Smith and Spackman (1955).
NH-(–)-12-isox-Leu-Val-CONH2 (6)
1H NMR (300 MHz, CD3OD): δ 7.90 (d, J = 8.7Hz, 1H), 5.53
(dd, J = 9.5, 4.9Hz, 1H), 4.54 (dd, J = 9.8, 4.9Hz, 1H), 4.42 (t, J
= 8.8Hz, 1H), 4.26 – 4.17 (m, 1H), 3.90 – 3.84 (m, 1H), 3.89 –
3.75 (m, 2H), 3.58 – 3.49 (m, 2H), 3.22 (dd, J = 5.9, 4.1Hz, 1H),
2.05 (dq, J = 13.6, 6.8Hz, 1H), 1.80 – 1.59 (m, 3H), 1.05 – 0.82
(m, 12H) ppm.
13CNMR (75MHz, CD3OD): δ 147.47, 172.82, 159.52, 152.51,
85.48, 58.22, 52.96, 52.21, 50.55, 49.27, 40.31, 30.68, 24.54, 21.98,
20.47, 18.32, 17.08 ppm.
HRMS (ESI) [M + Na]+ calculated for C17H29N5O4Na:
390.2117, found: 390.2111.
NH-(+)-12-isox-Leu-Val-CONH2 (7)
1H NMR (300 MHz, CD3OD); δ 7.97 (d, J = 8.6Hz, 1H), 5.53
(dd, J = 9.5, 4.9Hz, 1H), 4.55 (m, 1H), 4.39 (m, 1H), 4.26 – 4.16
(m, 1H), 3.90 – 3.72 (m, 2H), 3.58 – 3.43 (m, 2H), 3.24 – 3.16 (m,
1H), 2.05 (m, 1H), 1.75 – 1.58 (m, 3H), 1.02 – 0.81 (m, 12H) ppm.
13CNMR (75MHz, CD3OD): δ 147.47, 172.99, 159.40, 152.40,
128.72, 85.21, 58.05, 53.12, 52.17, 50.66, 49.14, 40.21, 30.91, 29.36,
24.84, 21.99, 20.25, 18.26, 16.90 ppm.
HRMS (ESI) [M + Na]+ calculated for C17H29N5O4Na:
390.2117, found: 390.2111.
Molecular Modeling
Compound 9 and 10 were modeled in explicit solvent
with periodic boundary conditions using metadynamics and
restrained molecular dynamics simulations. For each of the
compounds two isomers (cis and trans with respect to the amide
bond) were considered, resulting in a set of four peptides. Such
molecules were solvated in a cubic box of 4 nm with chloroform
(compound 8) and acetonitrile (compound 10) to reproduce the
NMR experiment conditions. Every system has been submitted to
geometry optimization with the steepest descent algorithm with
a convergence of 100 kJ mol−1 nm−1. Then we performed a 1
ns equilibration in NVT conditions at 300K, followed by a 1
ns NPT equilibration at the 1 bar and at the same temperature.
After the equilibration phase, we ran a 50 ns Well Tempered
Metadynamics (WTMD) with a 8.0 kJ mol−1 bias-factor, at a
reference temperature of 300K. To study the open and closed
state of both peptides, we selected as collective variable (CV)
the distance between CβVAL and the N-tert-butoxy carbonyl
(N-Boc) quaternary carbon. A Gaussian hill with σ = 0.1 Å and
an initial height of 1 kJ mol−1 was added once every 100 steps.
The simulation was sped up by saving the Gaussian hills on a grid
that ranged from 0 to 16 Å and spaced 0.02 Å. Compound 10
was also simulated using a 50 ns restrained molecular dynamics.
Special potentials are used for imposing restraints on the motion
of the system, to include knowledge from experimental data such
as the NMR derived interatomic distances. Distance restraints
add a penalty to the potential when the distance between specified
pairs of atoms exceeds a threshold value (Abraham et al., 2014).
The threshold values used in our simulation are reported in
the Supplementary Materials.
The restraints are applied in a progressive way to give
time to the peptide to relax, using a τ equal to 500 ps.
Since we are using multiple distance restraints, they are
not necessary satisfied at each simulation step but as a
time average. The atoms restrained and the relative distances
are shown in Table S1. Compound 9 and 10 have been
described using the Amber99SB-ILDN Force Field (Hornak
et al., 2006). 4,5,6,6a-Tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-
3-carboxylic acid residues were parameterized according to
standard procedures as explained in reference (Gandini et al.,
2018). During molecular dynamics (MD) and metadynamics
simulations, temperature was held constant with the v-rescale
algorithm (Bussi et al., 2007), while pressure was kept constant
through the Berendsen barostat (Berendsen et al., 1984). MD
simulations were performed using the leap-frog algorithm with 2
fs time-step, with holonomic constraints on every bond enforced
using the LINCS algorithm. Simulations and subsequent analysis
were performed with the GROMACS 5.0.4 (Van Der Spoel et al.,
2005) program suite, while metadynamics was run along with
PLUMED version 2.2.2 (Tribello et al., 2014).
RESULTS AND DISCUSSION
The two enantiomers of compound 1 were obtained starting
from the corresponding ethyl esters recently described
by us (Tamborini et al., 2015). Racemate (±)-2 (Conti
et al., 2006) was synthesized in a flow chemistry reactor
exploiting the 1,3-dipolar cycloaddition reaction of N-
Boc-3-pyrroline with ethoxycarbonyl formonitrile oxide.
An excellent enantiomeric separation (e.e. >99%) of the
racemate was achieved by semi-preparative chiral HPLC.
Alkaline hydrolysis of (–)-(3aS6aR)-2 and (+)-(3aR6aS)-
2 gave the desired (–)-(3aS6aR)-1 and (+)-(3aR6aS)-1,
respectively (Scheme 1).
The ability of compound 1 to stabilize secondary structures
was evaluated in model peptides containing (L)-Phe at
N-terminus and (L)-Leu-(L)-Val sequence at C-terminus
and (Schemes 2, 3). This last dipeptide was chosen as
it normally adopts extended conformation in solution.
Compound 1 was used in both the 3aS6aR and 3aR6aS
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stereochemistries [(–)-1 and (+)-1, respectively], as a
different effect on peptide conformations could be expected
depending on the stereochemistry of the unnatural amino
acids (Pellegrino et al., 2012).
Firstly, Leu-Val dipeptide 3 was prepared starting from
(L)-Valinamide and NH-Boc-(L)-Leu, according to the general
coupling procedure, followed by N-terminus deprotection
in TFA (91% overall yield). Diastereoisomeric dipeptides 4
and 5 were then achieved in good yields (65% and 63%,
respectively) by a coupling reaction of (–)-1 or (+)-1 with
dipeptide 3 (Scheme 2).
Both 4 and 5 compounds were completely characterized
by NMR spectroscopy (CDCl3, see SI for complete proton
assignment). In both tripeptides, no significant Noesy effects
between Leu-Val dipeptide and the scaffold were detected.
Furthermore, in variable temperature experiments, the obtained
1δ/1T is higher than 5 ppb/K for all the amide protons,
indicating the absence of H-bonds stabilizing a particular
SCHEME 1 | 1N NaOH, MeOH, r.t., 1h.
conformation. The JNH−CHα value for NH-Val is of 8.8Hz
and 7.9Hz, for 4 and 5, respectively (NH-Leu appears as a
broad signal for each compound). From these findings, we
hypothesized that both 4 and 5 adopt an extended conformation
and that the isoxazoline scaffold is not interacting with Leu-
Val dipeptide.
The peptide chain was then elongated at N-terminus, through
Boc-deprotection and coupling with (L)-Phe. Diastereoisomeric
dipeptides 8 and 9 were achieved in good overall yields (73%
and 76%, respectively) (Scheme 3). From NMR studies, it was
found that both model peptides 8 and 9 are present as a mixture
of conformers in 2:1 ratio in CDCl3 solution. The presence of
these two conformers is probably due to the low-energy barrier
cis/trans isomerization of the tertiary amide on the pyrrolidine as
it is frequently observed on the acylated proline and in the case of
tertiary cyclic amides (Laursen et al., 2013; Pellegrino et al., 2014).
Regarding compound 8, this rotation led to a splitting of the
(L)-Phe proton signals only. Furthermore, no significative Noesy
effects were detected, and, in variable temperature experiments,
the obtained1δ/1T coefficient is high for all the amide protons.
Taking all these data together, we can assume that Phe and Leu-
Val dipeptide are oriented in opposite directions and that the
3aS6aR stereochemistry of the scaffold is not effective in inducing
specific secondary structures when used in combination with
(L)-α-amino acids.
A different scenario was observed for compound 9. Its two
rotamers are indeed characterized by different chemical shifts,
suggesting that the isomerization of the tertiary amide leads
to two different structures conformations influencing the entire
molecule. Unfortunately, due to several overlapping signals, it
was not possible to assessing significative Noesy proximities.
Variable temperature experiments were thus done, in order to
investigate if the NH were involved in hydrogen bonds and, as
a consequence, if the two isomers of 9 were characterized by a
stable conformation in solution. In the case of the major isomer,
the obtained 1δ/1T is around 4 ppb/K for NH-Phe, indicating
that this proton could be involved in a weak/medium hydrogen
bond. All the other amide protons had higher 1δ/1T. On the
SCHEME 2 | Reagents and conditions: a) EDC/HOBt/DIEA, CH2Cl2 from 0
◦C to r.t., 24 h.
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SCHEME 3 | Reagents and conditions: a) TFA, CH2Cl2 from 0
◦C to r.t, 2 h; b) EDC/HOBt/DIEA, N-Boc-(L)-Phe, CH2Cl2 from 0
◦C to r.t, 24 h; c) EDC/HOBt/DIEA,
N-Boc-(L)-Phe-Gly-OH, CH2Cl2 from 0
◦C to r.t, 24 h.
FIGURE 2 | Cis and trans isomers of compound 9.
FIGURE 3 | Potential energy as a function of distance between Boc
quaternary carbon and CβVal obtained from Metadynamics for the two
isomers of compound 9 in chloroform.
other hand, in the minor conformer the obtained 1δ/1T is
of around 2 ppb/K for NH-Val, indicating that this proton is
involved in a strong hydrogen bond. Metadynamic studies were
then performed on the cis/trans tertiary amide conformers of
compound 9 (Figure 2).
In particular, we performed two 50 ns long metadynamics
simulations, using the distance between Boc quaternary carbon
and CβVal as collective variable (CV). This geometric parameter
was selected as a suitable CV because it discriminates well
between closed and extended states of the peptide. In this way,
it could be possible to evaluate if the two conformers had an
intrinsic tendency toward turn conformation. The cis isomer
showed a broad free energy minimum corresponding to CV
values between 5 and 8 Å, while the trans isomer showed much
higher free energy values in this region, exhibiting a shallow
minimum around 10–15 Å (Figure 3).
This different behavior could be indicative of a preference
of cis-9 toward a more closed conformation, although from
these data it was not possible to make any further assumptions.
For this reason, we envisaged that the introduction of a Gly
residue between Phe and isoxazoline scaffold could increase
the conformational flexibility of the N-terminus peptide arm
favoring its interaction with the C-teminus part of the
molecule. Compound 7 was thus elongated at N-terminus,
through coupling with N-Boc-(L)-Phe-Gly-OH dipeptide using
general coupling reaction conditions to obtain peptide 10
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FIGURE 4 | Noesy proximity (red) observed for compound 10 (CD3CN). On the top right: zoom of the amide region. On the bottom left: Zoom of the aliphatic region.
On the bottom right: zoom of the NH-aliphatic region.
(65%, Scheme 3). The NMR study on 10 (CD3CN, see
SI for complete assignment), showed that it is present in
solution as a single stable conformer (only trace amounts of a
second isomer were detected). A complete set of NHi-NHi+1
Noesy proximities, whose calculated distances ranged from
2.68 to 2.96 Å, were observed (Figure 4 on the top right).
Furthermore, long range Noesy effects involving HαGly and
NHVal (3.03 Å) and HβLeu (2.73 Å) were found (Figure 4 on
the bottom).
In variable temperature experiments (Figure 5), the obtained
1δ/1T is of around 2 ppb/K for NH-Val, while NH-Leu and
one of the C-terminus amide protons possess 1δ/1T of around
3 and 4 ppb/K, respectively. The presence of hydrogen bonds
was also confirmed by FT-IR analysis. N-H stretching bands
A and B (3,500–3,000 cm−1region, Figure S20) are indeed
downshifted as frequently observed in intramolecular hydrogen
bonded conformations (Tonan and Ikawa, 1996; Barth, 2007).
Furthermore, the deconvolution of the amide I band (1,700–
1,600 cm−1) showed the presence of a band at 1,655 cm−1
(Figure S20), typical of α structures (Kong and Yu, 2007).
In order to gain more information on the conformation
of compound 10, far-UV circular dichroism (CD) analysis in
CH3CN (0.1mM solution) was then performed. In Figure 6 the
obtained CD spectrum is reported.
It showed a maximum at around 250 nm due to the strong
absorption of the isoxazoline ring, as observed by Memeo et al.
(2018) on similar compounds (see also the UV spectrum in
the SI). In the amide bond region, two negative minima at 225
and 208 nm, with the same intensity, and a slightly positive
band at 200 nm were also observed. The presence of the exciton
splitting of the pi→ pi∗ transition band suggested that a α-turn
conformation was present (Wang et al., 2018), although in short
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FIGURE 5 | Variable temperature coefficients of the amide protons (CD3CN).
FIGURE 6 | CD spectrum of compound 10 in CH3CN (0.1mM CH3CN
solution).
peptides it is difficult to correctly evaluate the intensity of Cotton
effects with respect to secondary structure motifs (Chin et al.,
2002; Wang et al., 2018).
In order to completely elucidate the conformation of peptide
10, a restrained molecular dynamic was finally performed.
The restraints were based on the obtained NOESY values.
When the hydrogen was not uniquely defined, like in HαGly
and HβLeu, we used the closest carbon, e.g., CαGly and
CβLeu to implement distance restrains (Figure S3). The analysis
showed that CαGly-CβLeu (A) and CαGly-HNHVal (B) are
mutually exclusive in the trans isomer but not in the cis
one as shown in Figure S1. Furthermore, H-bond analysis
resulted in the observation that a H-bond is between CO-
Gly and NH-Val. In Figure 7 the most representative structure
is reported.
Taking together both experimental and molecular modeling
data, we can assume that, in solution, compound 10 effectively
adopts a α-turn conformation. This motif is normally formed
FIGURE 7 | Compound 10 conformation during the restained MD.
by 5 α-amino acids and is characterized by a H-bond between
i and i+4 residues. In our case, the isoxazoline scaffold replaces
two of the three core amino acids (Figure 1) and the H-bond is
formed by the CO-Gly and NH-Val, leading to the formation of
a 12 member pseudo-cycle. Furthermore, the overall structure
of the peptidomimetic is reinforced by medium-weak H-bonds
involving NH-Leu and one C-terminus-NH2, as evicted from
NMR data. The presence of a α-turn conformation is also
confirmed by the computational analysis of the dihedral angles
of the residue i+3 and of the distances between residues i and
i+4 (Table S9), as their values rely within the α-turn parameters
(Pavone et al., 1996).
In conclusion, as α-turns are often found on biologically
active sites and few molecules have been reported
to mimic or stabilize them, the ability of compound
(+)-1 to stabilize α-turn conformation on isolated
peptide is particularly important in view of future
biological applications.
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